Cantop 2.5mg Injection

Cantop 2.5mg Injection is given as an IV infusion into vein by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include tiredness, vomiting, weakness, nausea, and abdominal pain. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Inform your doctor if you notice fever, chills, sore throat, and severe diarrhea. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Ovarian cancer

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Cantop 2.5mg Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase I) involved in DNA multiplication of the cancer cells. This slows the growth of cancer cells and eventually kills them.

If you miss a dose of Cantop 2.5mg Injection, please consult your doctor.

Cantop 2.5mg Injection helps treat ovarian cancer.

It is given by a drip into a vein (intravenous infusion).

Do not drive or operate machinery as Cantop 2.5mg Injection may cause tiredness, drowsiness or weakness.

Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.

Your doctor may get regular blood tests done to monitor your blood cells during treatment with this medicine.

Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.

Q. How often is Cantop 2.5mg Injection given?

Generally Cantop 2.5mg Injection treatment is for 4 cycles of 21 day each, patient is given Cantop 2.5mg Injection for first 5 days of each cycle.

Q. Does Cantop 2.5mg Injection cause hair loss?

Yes, Cantop 2.5mg Injection may cause temporary hair loss.

Q. Does Cantop 2.5mg Injection cause flare reaction?

Yes, Cantop 2.5mg Injection may cause flare reaction.

Q. How long does Cantop 2.5mg Injection take to work?

Cantop 2.5mg Injection may start its action once the infusion is started, however, the complete effect may be assessed only after completion of 4 cycles.

Q. Is Cantop 2.5mg Injection a vesicant?

Cantop 2.5mg Injection is a vesicant (irritant).

Q. Is Cantop 2.5mg Injection effective?

Yes Cantop 2.5mg Injection is effective if used at prescribed doses for the prescribed duration as advised by your doctor.

Q. What is Cantop 2.5mg Injection chemotherapy?

It is a treatment therapy that includes Cantop 2.5mg Injection with or without combination of other drugs in treatment of cancer (Usually ovarian or lung cancer).

Q. How is Cantop 2.5mg Injection administered?

Cantop 2.5mg Injection is either administered orally as a capsule or as an intravenous Infusion in the arm over a period of 30 min.

In Ovarian cancer

Ovarian cancer is a cancer that begins in the female organs that produce eggs (ovaries). This type of cancer is usually detected very late and can be fatal too. It usually spreads to the pelvis and stomach. Cantop 2.5mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but has some side effects that may be bothersome. Consult your doctor to know about ways that can help you avoid these side effects.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Injection site reactions (pain, swelling, redness)

Diarrhea

Decreased blood cells (red cells, white cells, and platelets)

Decreased white blood cell count

Indigestion

Abdominal pain

Nausea

Weakness

Vomiting

Tiredness

Alcohol:SAFE

Consuming alcohol with Cantop 2.5mg Injection does not cause any harmful side effects.

Pregnancy:CONSULT YOUR DOCTOR

Cantop 2.5mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding:UNSAFE

Cantop 2.5mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving:UNSAFE

Cantop 2.5mg Injection may cause side effects which could affect your ability to drive.Cantop 2.5mg Injection can make you feel tired and this may affect your ability to drive.

Kidney:CAUTION

Cantop 2.5mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Cantop 2.5mg Injection may be needed. Please consult your doctor.Use of Cantop 2.5mg Injection is not recommended in patients with end-stage kidney disease.

Liver:SAFE IF PRESCRIBED

Cantop 2.5mg Injection is safe to use in patients with liver disease. No dose adjustment of Cantop 2.5mg Injection is recommended.

Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1711-12.

Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 951.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1383.

Topotecan hydrochloride. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 1996 . view

Topotecan. Unterach, Austria: Ebewe Pharma; 1996 . view

Central Drugs Standard Control Organisation . view

Drugs and Lactation Database. Bethesda : National Library of Medicine ; 2006. Topotecan. . view